Kolexia
Le Bris Yannick
Pharmacien
Hôpital Hôtel-Dieu Nantes
Nantes, France
164 Activités
369 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Leucémie aigüe myéloïde Leucémies Lymphome à cellules du manteau Leucémie myéloïde Syndromes myélodysplasiques Lymphome B Tumeurs hématologiques Thrombose

Industries

Janssen
6 collaboration(s)
Dernière en 2021
Astellas
2 collaboration(s)
Dernière en 2021
Pfizer
2 collaboration(s)
Dernière en 2021
Incyte
1 collaboration(s)
Dernière en 2023

Dernières activités

Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.
Haematologica   08 février 2024
Susceptibility to mycobacterial infection in VEXAS syndrome.
Rheumatology (Oxford, England)   05 février 2024
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.
American journal of hematology   02 janvier 2024
Optical Genome Mapping. Contribution to the Etiological Diagnosis of Developmental disorders : experience of the Nantes Genetic Department on over 60 individuals
Abstracts from the 56th European Society of Human Genetics (ESHG) Conference   01 janvier 2024
A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals major role of BAX in BH3 mimetics response.
Blood   14 décembre 2023
Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia.
Blood advances   21 novembre 2023
CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma.
Blood   07 novembre 2023
Optical Genome Mapping Provides New Molecular Insights in High-Risk Mantle Cell Lymphoma: A Lysa Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Deep Learning Based Blood Abnormalities Detection As a Tool for Vexas Syndrome Screening
65th ASH Annual Meeting Abstracts   02 novembre 2023
Optical Genome Mapping Combined with High-Throughput Sequencing Is Effective for the Diagnostic and Prognostic Genomic Classification of Acute Myeloid Leukemia and Myelodysplastic Neoplasms
65th ASH Annual Meeting Abstracts   02 novembre 2023